Omega-3s May Help Reduce Progression of Non-Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is characterized by the build-up of fat in the liver of people who drink very little or no alcohol and can be a complication of metabolic syndrome. A recent study suggests that eating more long-chain omega-3 fatty acids may help reduce the progression of non-alcoholic fatty liver disease.
For this study, researchers analyzed data from 18 studies in which the independent effects of long-chain omega-3 fatty acids could be isolated. The researchers found that NAFLD was present in 42.6% of adults with diabetes in the UK and in 69.5% of adults with diabetes in Italy. They found a range in children from 2% to 12.5%, with a higher range in obese children, 36% of whom in Germany had NAFLD and 44% of whom in Italy had NAFLD.
Supplementation with omega-3’s was associated with statistically significant improvements in six of 13 metabolic risk factors, in levels of two of three liver enzymes, in liver fat content, and in steatosis score.
The researchers found that the minimum effective daily intake to be 250 mg of DHA in pediatric patients and 3 grams of EPA and DHA in adults.
Researchers from Intertek Scientific & Regulatory Consultancy in Canada led the study. It was published on August 1, 2018, in Nutrition Reviews.
Because omega-3 fatty-acids are not found naturally in the human body, it is especially important to make sure that they are a part of your daily diet. Oily, dark fish such as tuna and salmon are high in omega-3s. For people who don’t like fish, consider taking a daily high-quality non-fish supplement that has been tested for purity and potency.